 |
|
|
|
Jim
Furniss
BA (Hons)
Jim Furniss is Director, Market Access Solutions
at Bridgehead International. He has a detailed understanding of
pharmaceutical policy, pricing and market access issues throughout
Europe and North America and extensive practical experience of Company-Government
relations in drug pricing and reimbursement.
Prior to moving into consultancy Jim was head of the Pharmaceutical
Industry Branch in the UK Department of Health from 1991 to 1997.
In this position, he was responsible for the operation of the UK
Pharmaceutical Price Regulation Scheme and for the NHS drug budget
for the UK. During this time he also represented the UK on pharmaceutical
issues at the European Commission. He gained valuable experience
in pharmaceutical price regulation across Europe as a member of
the European Commission’s Pharmaceutical Pricing Transparency
Committee. He also worked with Senator Pryor and the US General
Accounting Office on international drug pricing issues.
Jim has spent more than 10 years in consultancy in the pharmaceutical
industry, initially with Cambridge Pharma Consultancy and most recently
with Bridgehead International. During this time he has worked for
a large number of pharmaceutical pricing, reimbursement and market
access projects, covering all major therapy areas. His work has
been primarily focused on market access for new products in European
and North American markets, and the development of payer value propositions
and payer-focused market access strategies; but he has also worked
on medical devices and diagnostics, and on the implications for
pharmaceutical companies of broader healthcare policy development.
He has worked with all the major international pharmaceutical companies
and many smaller companies. He is a regular speaker at international
conferences on pharmaceutical pricing, reimbursement and market
access issues.
Top
|
